4.1 Article Data Paper

Dataset for the study of the effect of anticoagulation in the incidence of stroke and other outcomes in patients with left ventricular thrombus

Journal

DATA IN BRIEF
Volume 50, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.dib.2023.109469

Keywords

Acute myocardial infarction; Anticoagulation; Direct oral anticoagulants; Left ventricular thrombus; Mortality; Treatment; Stroke; Vitamin K antagonists

Ask authors/readers for more resources

This study aims to assess the effect of duration of anticoagulation on the incidence of stroke in patients with left ventricular thrombus (LVT) by collecting clinical data, including treatment choices, treatment duration, reasons for treatment interruption, occurrence of stroke, and other relevant information. The methodology used in this study allows for future analysis of the data and recruitment of more patients to increase statistical power.
The optimal duration of anticoagulation in patients with left ventricular thrombus (LVT) is unknown. The data package herein presented contains the information used to assess the effect of duration of anticoagulation in the incidence of stroke in patients with left ventricular thrombus (LVT) in a tertiary hospital. In order to collect the required data, all transthoracic echocardiography studies at our institution from January 1st 2014 to December 31st 2021 with LVT were retrieved using dedicated software (Phillips Intellispace Cardiovascular; Koninklijke Phillips N.V., 2004-2020). Second, a dataset was designed ad hoc for this study in which the recruited data for the predefined objectives were obtained from electronic medical records. These data included clinical and demographic information including treatment choices (vitamin K antagonists [VKA] versus direct oral anticoagulants [DOAC]), duration of treatment, reason for interruption of treatment, occurrence of stroke, acute myocardial infarction, bleeding events, thrombus resolution, recurrence, and death. Retrieved data were stored in an excel sheet for analysis using the statistical package STATA (StataCorp v. 15.0, College station, TX). This methodology allows the reuse of these data for further analysis, in the context of the present study and also for future recruitment of additional patients from other institutions to increase statistical power. (C) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available